A controlled trial in coalminers under the age of 50 in South Wales with sputum-negative, early complicated pneumoconiosis was used to compare three regimes: (1) showed significantly less progression than those with a positive Mantoux. The lack of benefit and the short-and long-term complications of chemotherapy (weight gain, reduction in ventilatory capacity, dyspepsia, and streptomycin toxicity) show that this treatment is contra-indicated in miners with early complicated pneumoconiosis without a positive sputum. That new shadows develop during chemotherapy adds to the evidence from other sources that tuberculosis is unlikely to be a major factor in the pathogenesis of complicated pneumoconiosis in this area. Mycobacterium peregrinum (Runyon group IV) was isolated in three cases.
If a further trial was to be made, it was essential that the scientific, technical, and ethical aspects should be considered in detail. To do this a committee was convened by the Medical Research Council under Professor C. H. Stuart-Harris in 1958. The unanimous conclusion of the committee was that a further trial was desirable but 'grave doubts were expressed on the possibility of completing the trial successfully'. The trial differed from most anti-tuberculosis chemotherapy trials in important respects which made it unusually difficult: (1) By definition the cases admitted did not have tubercle bacilli in the sputum, so a valuable index of the effect of therapy was removed. (2) The lesion in P.M.F. progresses more slowly than does tuberculosis. (3) The fibrotic nature of the lesions made it probable that the trial would be one-sided in the sense that we should be able to detect only 'no change' or 'progression' and would not have the group of 'improvement' on which the results of most trials of drugs for tuberculosis are based radiologically. (4) Studies in the Rhondda (Cochrane and Carpenter, 1956 ) had produced some evidence that the progression of the disease might be linked with physical activity, so a test of this factor had to be included in the design of the trial.
PLAN OF TRIAL
The original plan was to follow up over a period of at least three years 225 working miners randomly allocated into the three groups shown in Table I . The group with hospital rest alone is unusual and was put in for the reasons mentioned, and because of the great importance of achieving an unambiguous result from a trial which might not be repeatable. At the time the trial was started, the results of the Madras study (Fox, 1962) , showing the negligible benefit of hospital rest in tuberculosis, were not available. In selecting the chemotherapy we were forced to compromise between a regimen which was certainly adequate to control any active tuberculous focus and one which could and would be taken by a majority of miners when back at work. The addition of steroids was considered but rejected on account of the possible risk of complications and the absence of evidence of benefit in ward cases.
CRITERIA FOR SELECTION The subjects were working miners up to the age of 50, sputum-negative (6 or more negative cultures), and showing on the chest film opacitiees of a total diameter no,t exceeding 8 cm., thought by a majority of a panel of three to be examples of complicated pneumoconiosis of coalworkers. In miners fulfilling these criteria the only reason for exclusion was a history of previous treatment with anti-tuberculosi-s drugs or the presence of another condition sufficiently severe to make it improbable that the man would be able to continue his ernployment and be followed over a period of three years at least.
POPULATION SELECTION The trial started at the time of the first periodic survey by the National Coal Board. This ensured that working miners who came within the criteria for the trial could be recruited from the who-le of -the South Wales coailfield. The majority of men were recruited from this survey. A few came from those who applied for compensation to the Pneumoconiosis Medical Panels. The results are, therefore, likely to be applicable at least to the whole of the South Wales area. The purpose of the trial was explained to the miners and the Union representatives at all levels. Over two-thirds of those asked by the doctors of the National Coal Board or the Pneumoconiosis Panels agreed to attend the Pneumoconiosis Research Unit for interview. Of those who attended, all but one who were suitable agreed to take part in the investigation. The trial remained open for three years and was closed after 180 out of the anticipated 225 had been enrolled. One of three treatment regimes was randomly selected within groups of six as the men attended for interview. COURSE OF TRIAL At the ini-tial interview a PA chest radiograph, answers to a questionnaire on chest symptoms, previous illnesses, and smoking habits, and industrial history were obtained. A full physical examination was made and specimens of blood, urine, and sputum were collected. The forced expiratory volume (FEVo.75) and forced vital capacity (FVC) were recorded (McKerrow, McDermott, and Gilson, 1960) , and a Mantoux test was done. These procedures were repeated at 3, 12, 24, and 36 months.
One man developed a TB-positive sputum and was withdrawn from the trial. 168 cm. in height is 3.3 1. (Cotes, Rossiter, Higgins, and Gilson, 1966) . This corresponds to an FEVo.75 of 2-95 1. (McKerrow, McDermott, and Gilson, 1960) . Thus the average figure of 2-71 1. (Table III) is only slightly below normal, confirning the view that early P.M.F. has little influence on ventilatory capacity (Cochrane and Higgins, 1961 Tables IV   TABLE IV AGREEMENT BETWEEN OBSERVERS group.bmj.com on June 25, 2017 -Published by http://thorax.bmj.com/ Downloaded from tendency to record smaller differences which were ignored by X.
In Table V the only notable difference between the treatment groups is that observer X assessed more cases as 'no change' in the 'resit' group than in the other two groups, but this difference was not significant at the 5% level (P=007). The Table shows that the difference is due to fewer cases of 'doubtful progression' in the 'rest' group and not to a reduction in the number of 'definite progressions'. (2) 10(2) 28(2) 2 (1) A total of 12 patients probably took less than half their total chemotherapy. We examined the possibility that these patients formed a large proportion of those with progression on the radiographs, but this was not so. Removing these patients from the analysis did not alter the conclusions reached in the previous section.
DISADVANTAGES OF THERAPY
Streptomycin vertigo Vertigo was sufficiently marked to stop treatment in five cases after 29-57 g had been given, at between the fourth and eighth weeks. The vertigo disappeared within a few weeks in one subject, but continued to be sli-ght or moderate in the dark, though negligible in daylight, for over three years in four men.
A further nine cases had only slight vertigo and treatment was not stopped in these. The vertigo ceased within 2-8 weeks of completing the 3-months course in eight cases but was still noticed occasionally nine months later by one man. Dyspepsia Dyspepsia occurred at some time in 16 patients. It was fairly severe in seven of them. The dyspeptic symptoms in these cases started between the fifth and ninth month of treatment; as a result, the total number of cachets taken was between 50% and 80% of the prescribed dose over the nine months. The nine cases of slight dyspepsia developed in the course usually at about three months. Six of these completed their full treatment in spite of dyspepsia; the other three took between 50 and 85% of the prescribed dose. Six patients suffered from both vertigo and dyspepsia.
Weight rise Figure 3 shows that the average weight of the men in the two groups going to hospital rose steeply during the three months' admission, the rise being greater in the group without drugs. The mean weight rise of the rest group was 4-3 kg. ; in those on chermotherapy with no dyspepsia, 2-8 kg.; and of the 19 men with dyspepsia from P.A.S., 2-0 kg. This weight rise (not seen in the workinig group) delayed some miners returning to full work at once on account of increased breathlessness, but within 18 months the effect on weight was reversed. Fall in ventilatory capacity Figure 3 also shows the changes in ventilatory capacity. There was a sharp fall in the first three months in the two grou-ps in hospital, but by 24 months the difference between the three groups had disappeared. These and other changes in lung function have been reported in detail elsewhere (Cotes and Gilson, 1967) . It was concluded that the fall in F.E.V. was due to the weight increase and unrelated to the inactivity, the smoking halbits, or the chemotherapy, except in so far as these factors affected the weight.
Employment We expected that a period in hospital might affect the pattern of employment compared with those in the working group. Table   VI shows that the groups wbo were treated in hospital had a work reoord at one year very similar to that of the working group. Of the five men in the chemotherapy group who were unemployed at one year, two had persistent streptomycin vertigo. One of these later returned to light work; the other developed a disabling compensation neurosis, partly the result of vertigo. The other three were unemployed for reasons unrelated to the trial. To summarize the disadvanta-ges of the treatment, the persistent ill-effect was vertigo in the dark in four miners, two of wihom remained unemployed for long periods. The transient illeffects were weight gain, impaired ventilatory capacity, and dyspepsia.
CORRELATION BETWEEN PROGRESSION AND OTHER
FINDINGS This trial gave an opportunity to look at correlations ibetween radiological progression over three years and chest symptoms; smoking habits; E.S.R.; tuberculin sensitivity; and rheumatoid factor.
Chest symptoms None of the symptoms recorded on the questionn;aire at the start of the trial showed any correlation with radiological progression or change in area, nor were they related to the treatment group.
Smoking Analysis of the relation of initial smoking habits divided into four groups (nonsmokers; ex-smokers; light (<15 cigarettes/ day); and heavy smokers (>15 cigarettes/day) ) showed no association with the initial area of the shadows or the change of area over three years. Hart, Cochrane, and Higgins (1963) , who used 5 T.U., though the mean was naturally somewhat larger, 13-9 mm. in our series compared with their mean of 104 mm. Rheumatoid factor Aggregated human yglobulin (AHGG) was used to detect rheumatoid factor in the serum by the method described by Pernis, Vigliani, and Selikoff (1965) . This measurement was made towards the end of the trial; 157 subjects were tested and the titre at 36 months was used. Forty-two (27%) showed a titre positive a;bove 1 in 10, 21 of these being positive at 1 in 80 or above. The trial has shown that there are particular difficulties in measuring small changes in illdefined radiographic shadows in complicated pneumoconiosis even over a three-year period. After using the two methods of assessing the radiographs and two observers, we concluded that one year of anti-tuberculosis chemotherapy, with as high a dose as is practicable, had no significant effect on the progression of the disease followed over three years. Although this is true of the total series, there is a little evidence to indicate that there may 'be a small sub-group of patients who do respond to treatment, (but unfortunately if they exist we found no means of predicting them, either from a special study of the characteristics of the shadows, or the E.S.R., or other factors. Those with a negative Mantoux 1 T.U. initially are slightly but significantly less likely to progress.
The conclusion, that the disease as measured by the radiographic appearance is not influenced by this treatment has practical therapeutic implications, because chemotherapy in hospital had appreciable transient and occasional long-term illeffects. In particular, the -late effects of streptomycin toxicity, which may be only a slight inconvenience to most patients, may prevent a miner continuing to work underground because it is much more disabling in poor light and when carrying loads on uneven ground. We therefore conclude that in the albsence of means of predicting those who Will respond-if they exist-anti-tuberculosis chemotherapy is not justified in miners with P.M.F. who are sputum-negative for tubercle bacilli. The trial supports the conclusions of the only two previous controlled trials of this kind (Miall et al., 1954; McCallum, 1961) . We considered the use of steroids and antituberculosis therapy in planning the trial but rejected the idea on account of the risk of complications. Our views are not altered after completion of the trial.
This trial adds a little to the evidence from other sources (Cochrane, 1962; Hart et al., 1963) that tuberculosis is probably not a major factor in the pathogenesis of P.M.F. As chemotherapy did not prevent the development of new shadows, tuberculous infection probably does not initiate the new foci of P.M.F. The lack of effect of chemotherapy on the progression suggests that tuberculosis is not responsible at this later stage in a majority of cases. However, the slender evidence from this trial and the earlier one by Miall et al. (1954) , that chemotherapy may benefit a small proportion of cases even though these cannot be identified ahead, could be interpreted as supporting the view that P.M.F. has more than one aetiology. The diagnosis in life is radiological; it is known that some cases diagnosed as P.M.F. have a positive sputum and respond well to therapy (M.R.C. / Miners' Treatment Centre Trials, 1963), but these cases cannot be identified for certain on radiological features alone. If P.M.F. has a multiple aetiology-silicotic in some cases, immunological in others, and tuberculous in a few one might expect to find a case developing a positive sputium even though previously sputum negative. This occurred in one instance in this trial.
The negative results do not exclude the possibility that a mycobacterial infection resistant to the drugs used may also play a part in the pathogenesis of complicated pneumoconmiosis. There is evidence of an association between coalworkers' pne,umoconiosis and drug-resistant anonymous mycobacterial infection (Kamat, Rossiter, and Gilson, 1961) , and three cases of intermittent positive sputum with M. peregrinum (Runyon group IV) were observed in the trial, ibut their course over three years did not differ obviously from the rest. 
